Navigation Links
Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
Date:8/1/2013

CHESTERBROOK, Pa., Aug. 1, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company, today announced financial results for the quarter ending on June 30, 2013.  The Company also highlighted select commercial, regulatory and clinical development progress in the second quarter of 2013 and has updated its previously announced financial guidance for 2013.

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO )

For the quarter ended June 30, 2013, Auxilium reported net revenues of $100.5 million, compared to net revenues of $78.2 million in the second quarter of 2012, an increase of 29%.  For the second quarter of 2013, XIAFLEX® U.S. net revenues increased by 26% over the comparable 2012 period  and U.S. Testim® net revenues decreased by 15% .  Revenues from Auxilium's recently acquired subsidiary, Actient Holdings LLC, resulted in sales for the period of April 26, 2013 (the date of the acquisition) through June 30, 2013 of $27.3 million. 

Auxilium reported net income for the quarter ending June 30, 2013 of $11.0 million, or $0.22 per share on a non-GAAP basis compared to non-GAAP net income of $11.6 million, or $0.24 per share for the quarter ending June 30, 2012.  On a U.S. GAAP basis, Auxilium reported net income of $57.1 million, or $1.16 per share basic and $1.15 per share fully diluted, compared to net income of $7.7 million, or $0.16  per share (basic and fully diluted), reported for the second quarter of 2012.  The U.S. GAAP results for the quarter ending June 30, 2013 included a $92.4 million tax benefit recorded as a result of the Actient acquisition.  The foregoing non-GAAP financial measures should not be relied upon as an alternative to GAAP measure
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
2. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
3. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
4. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
5. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
6. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
7. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
8. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
9. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
10. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
11. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... and HAMPTON, N.J. , March ... MNK ), a leading global specialty biopharmaceutical ... announced today that they have entered into a definitive ... Ikaria, Inc. from a Madison Dearborn -led investor ... Subject to customary closing conditions, the ...
(Date:3/5/2015)... , March 5, 2015  Asterias Biotherapeutics, Inc. ... emerging field of regenerative medicine, announced today that ... nation,s top rehabilitation hospitals for spinal cord injury and ... clinical trial of AST-OPC1 (oligodendrocyte progenitor cells) in newly ... cord injury (SCI). The Phase 1/2a ...
(Date:3/5/2015)... 2015  MGC Diagnostics Corporation (NASDAQ: ... reported financial results for the first quarter ended ... quarter domestic equipment, supplies and accessories revenues increased ... in the 2014 first quarter.  During the quarter, ... in revenue, compared to 14 accounts, or $662,000 ...
Breaking Medicine Technology:Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 12
(Date:3/5/2015)... 2015 Lakeview Regional Medical Center ... the annual American Heart Association’s Heart Walk as the ... Regional Chief Executive Officer, is serving as Chairman of ... 21, 2015 at Fontainebleau State Park beginning at 9AM. ... 20 individual teams participating in this year’s event. Anyone ...
(Date:3/5/2015)... 2015 New fiber fix heat wrap, a ... a one of a kind product, manufactured to withstand the ... in its short time in the market by customers who ... fiber glass objects which cannot be done with the usual ... really are excited about our new product Fiber Fix Heat ...
(Date:3/5/2015)... TULSA, OK (PRWEB) March 05, 2015 ... been to build a faster, safer, smarter commercial lifting ... the company has an increasing role in more ... lifting systems last month – Octapad System for lifting ... place concrete barriers during road construction projects. , ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 March ... and information campaign sponsored by the Academy of ... into a Healthy Lifestyle," which promotes the consumption ... exercise for achieving and maintaining a healthy weight, ... wellness. , Whether a person is new ...
(Date:3/5/2015)... Medical professionals suggest the physician shortage is ... that is worsening. The demand for doctors far exceeds ... top of the physician shortage, health care organizations and ... with physicians and advanced practitioners throughout the U.S. through ... , Physician openings take an average of 204 days ...
Breaking Medicine News(10 mins):Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 2Health News:Get Your Heart Set on Walking a Better "Path" - Lakeview Regional Medical Center Sponsors Northshore Heart Walk 3Health News:TheHardwareCity.com Launches New Fiber Fix Heat Wrap For High Temperature Applications 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 2Health News:New Vacuworx Concrete Lifting Systems Aid Safer, Greener Environment As Contractors Seek LEED Incentives 3Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 2Health News:National Nutrition Month® Tips for Athletes from the Austin Sports Medicine Team at Medicine in Motion 3Health News:Physician Shortage Crisis Worsening 2
... the findings of a UCSF study to be published ... and Gynecology," the risk of miscarriage in pregnant women ... chromosomal abnormalities is lower than previously believed. ,Two ... tests performed during the first and second trimester of ...
... suited to being vegetarians than meat-eaters is among the findings ... 300 leading scientists from New Zealand and overseas. The ... cancer is also under discussion at the conference. ... says the finding that a human is more suited to ...
... US-based Center for Disease Control and Prevention (CDC) ... pharmaceutical development company//, BioDiem, to conduct pre-clinical trials ... its Dutch partner Akzo Nobels Nobilon. ,The ... for research into the prevention and monitoring of ...
... content in cigarettes, thwarting smoking-cessation initiatives. Indeed many steps ... by many nations, inclusion of graphic warnings on cigarettes ... in the cigarettes, on the sly, in a bid ... unique study, the first of its kind undertaken to ...
... Inc.'s (MDT) Activa brain stimulation device, in combination with ... as quality of life in patients with advanced Parkinson's ... ,The study was published in Thursday's issue of the ... the Food and Drug Administration had approved the Activa ...
... of growth of colon polyps to half, it doubles the ... by two significant studies published in the Aug. 31 issue ... Bruce M. Psaty, M.D., Ph.D., and John D. Potter, M.B., ... with it. ,"These two trials provide strong evidence ...
Cached Medicine News:Health News:Prenatal Test and Miscarriage 2Health News:Prenatal Test and Miscarriage 3Health News:Medtronic Device Proves Effective in Parkinson’s Diseas 2Health News:Celebrex- pros and cons 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: